Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative bevacizumab before malignant glioma resection
jRCTs021260050Recruiting
- Start
- Oct 2026
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label trial of bevacizumab in malignant glioma (2 arms). Primary endpoint: Score of operative maneuver for hemostasis against tumor bleeding during surgery. Started Oct 2026; status: recruiting.
02
Drugs
bevacizumab
03
Conditions
malignant glioma
Beyond the preview
Go deeper on jRCTs021260050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs021260050.